. Cisc-uam and . Madrid, the 'Région Languedoc-Roussillon' (France) (to SD), the 'Agence Française de Biomedecine', the 'Société d'Accélération du Transfert de Technologies' Languedoc Roussillon (SATT, AxLR) (to SD) and by the Grant TPLIRBCELL (ANR-2010-BLANC-1117-01) from the 'Agence Nationale de la Recherche, INSERM and the SARL 'Médecine-Biologie-Méditerannée', pp.31-2008

M. Cnop, N. Welsh, J. Jörns, A. Lenzen, S. Eizirik et al., Mechanisms of pancreatic ?cell death in type 1 and type 2 diabetes: many differences, few similarities, Diabetes, vol.54, pp.97-107, 2005.

F. B. Barton, M. R. Rickels, A. R. Hering, B. J. Wease, S. Naziruddin et al., Improvement in outcomes of clinical islet transplantation: 1999-2010, Diabetes Care, vol.35, pp.1436-1445, 2012.

S. Lablanche, S. Borot, A. Wojtusciszyn, F. Bayle, R. Tetaz et al., Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL Network, Diabetes Care, vol.38, pp.1714-1722, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01850555

N. R. Barshes, S. Wyllie, and J. A. Goss, Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts, J Leukoc Biol, vol.77, pp.587-597, 2005.

T. Mandrup-poulsen, Interleukin-1 antagonists and other cytokine blockade strategies for type 1 diabetes, Rev Diabet Stud, vol.9, pp.338-347, 2012.

M. Y. Donath, M. Böni-schnetzler, H. Ellingsgaard, P. A. Halban, and J. A. Ehses, Cytokine production by islets in health and diabetes: cellular origin, regulation and function, Trends Endocrinol Metab, vol.21, pp.261-267, 2010.

M. Cetkovic-cvrlje and D. L. Eizirik, TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide, Cytokine, vol.6, pp.399-406, 1994.

A. Rabinovitch, W. Sumoski, R. V. Rajotte, and G. L. Warnock, Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture, J Clin Endocrinol Metab, vol.71, pp.152-156, 1990.

J. W. Ramadan, S. R. Steiner, C. M. O'neill, and C. S. Nunemaker, The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes, Cell Calcium, vol.50, pp.481-490, 2011.

S. R. Cechin, I. Perez-alvarez, E. Fenjves, R. D. Molano, A. Pileggi et al., Antiinflammatory properties of exenatide in human pancreatic islets, Cell Transplant, vol.21, pp.633-648, 2012.

R. N. Faradji, T. Tharavanij, S. Messinger, T. Froud, A. Pileggi et al., Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept, Transplantation, vol.86, pp.1658-1665, 2008.

K. Toyoda, T. Okitsu, S. Yamane, T. Uonaga, X. Liu et al., GLP-1 receptor signaling protects pancreatic beta cells in intraportal islet transplant by inhibiting apoptosis, Biochem Biophys Res Commun, vol.367, pp.793-798, 2008.

Y. Wang, M. Qi, J. J. Mcgarrigle, B. Rady, M. E. Davis et al., Use of glucagon-like peptide-1 agonists to improve islet graft performance, Curr Diab Rep, vol.13, pp.723-732, 2013.

L. Farilla, A. Bulotta, B. Hirshberg, L. Calzi, S. Khoury et al., Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets, Endocrinology, vol.144, pp.5149-5158, 2003.

L. Li, W. El-kholy, C. J. Rhodes, and P. L. Brubaker, Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B, Diabetologia, vol.48, pp.1339-1349, 2005.

N. A. Sherry, W. Chen, J. A. Kushner, M. Glandt, Q. Tang et al., Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells, Endocrinology, vol.148, pp.5136-5144, 2007.

S. Costes, C. Broca, G. Bertrand, A. Lajoix, D. Bataille et al., ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival, Diabetes, vol.55, pp.2220-2230, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00201283

M. A. Kalwat, S. M. Yoder, Z. Wang, and D. C. Thurmond, A p21-activated kinase (PAK1) signaling cascade coordinately regulates F-actin remodeling and insulin granule exocytosis in pancreatic ? cells, Biochem Pharmacol, vol.85, pp.808-816, 2013.

J. Quoyer, C. Longuet, C. Broca, N. Linck, S. Costes et al., GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells, J Biol Chem, vol.285, pp.1989-2002, 2010.

S. Das, J. Cho, I. Lambertz, M. A. Kelliher, A. G. Eliopoulos et al., Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner, J Biol Chem, vol.280, pp.23748-23757, 2005.

T. Gantke, S. Sriskantharajah, M. Sadowski, and S. C. Ley, IkappaB kinase regulation of the TPL-2/ ERK MAPK pathway, Immunol Rev, vol.246, pp.168-182, 2012.

J. Jager, T. Grémeaux, T. Gonzalez, S. Bonnafous, C. Debard et al., Tpl2 Kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1? and tumor necrosis factor-? effects on extracellular signal-regulated kinase activation and lipolysis, Diabetes, vol.59, pp.61-70, 2010.

C. Patriotis, M. G. Russeva, J. Lin, S. M. Srinivasula, D. Z. Markova et al., Tpl-2 induces apoptosis by promoting the assembly of protein complexes that contain caspase-9, the adapter protein Tvl-1, and procaspase-3, J Cell Physiol, vol.187, pp.176-187, 2001.

T. Yaomura, N. Tsuboi, Y. Urahama, A. Hobo, K. Sugimoto et al., Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury, Nephrology, vol.13, pp.397-404, 2008.

S. Beinke, M. J. Robinson, M. Hugunin, and S. C. Ley, Lipopolysaccharide activation of the TPL-2/ MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105, Mol Cell Biol, vol.24, pp.9658-9667, 2004.

P. L. Podolin, J. F. Callahan, B. J. Bolognese, Y. H. Li, K. Carlson et al., Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation, J Pharmacol Exp Ther, vol.312, pp.373-381, 2005.

B. Nilsson, K. N. Ekdahl, and O. Korsgren, Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment, Current Opin Organ Transplant, vol.16, pp.620-626, 2011.

J. Hirschhorn, S. Mohanty, and N. R. Bhat, The role of tumor progression locus 2 protein kinase in glial inflammatory response, J Neurochem, vol.128, pp.919-926, 2014.

C. M. Larsen, M. G. Døssing, S. Papa, G. Franzoso, N. Billestrup et al., Growth arrest-and DNA-damage-inducible 45beta gene inhibits c-Jun N-terminal kinase and extracellular signal-regulated kinase and decreases IL-1beta-induced apoptosis in insulinproducing INS-1E cells, Diabetologia, vol.49, pp.980-989, 2006.

L. Larsen, J. Storling, M. Darville, D. L. Eizirik, C. Bonny et al., Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaBmediated gene expression in insulin-producing INS-1E cells, Diabetologia, vol.48, pp.2582-2590, 2005.

K. Maedler, J. Størling, J. Sturis, R. A. Zuellig, G. A. Spinas et al., Glucose-and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signalregulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets, Diabetes, vol.53, pp.1706-1713, 2004.

D. Pavlovic, N. A. Andersen, T. Mandrup-poulsen, and D. L. Eizirik, Activation of extracellular signalregulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells, Eur Cytokine Netw, vol.11, pp.267-274, 2000.

J. Saldeen, J. C. Lee, and N. Welsh, Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis1, Biochem Pharmacol, vol.61, pp.1561-1569, 2001.

F. Ortis, P. Pirot, N. Naamane, A. Y. Kreins, J. Rasschaert et al., Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells, Diabetologia, vol.51, pp.1213-1225, 2008.

M. López-peláez, I. Soria-castro, L. Boscá, M. Fernández, and S. Alemany, Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression, Eur J Immunol, vol.41, pp.1733-1741, 2011.

K. L. Decicco-skinner, S. J. Nolan, M. M. Deshpande, E. L. Trovato, T. A. Dempsey et al., Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice, PLoS One, vol.8, p.56212, 2013.

N. Ogawa, J. F. List, J. F. Habener, and T. Maki, Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4, Diabetes, vol.53, pp.1700-1705, 2004.

Y. Kawasaki, S. Harashima, M. Sasaki, E. Mukai, Y. Nakamura et al., Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation, Horm Metab Res, vol.42, pp.311-317, 2010.

M. E. Kimple, M. P. Keller, M. R. Rabaglia, R. L. Pasker, J. C. Neuman et al., Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose-and hormone-stimulated insulin secretion, Diabetes, vol.62, pp.1904-1912, 2013.

T. Tabatabaie, A. M. Waldon, J. M. Jacob, R. A. Floyd, and Y. Kotake, COX-2 inhibition prevents insulindependent diabetes in low-dose streptozotocin-treated mice, Biochem Biophys Res Commun, vol.273, pp.699-704, 2000.

P. O. Tran, C. E. Gleason, and R. P. Robertson, Inhibition of interleukin-1beta-induced COX-2 and EP3 gene expression by sodium salicylate enhances pancreatic islet beta-cell function, Diabetes, vol.51, pp.1772-1778, 2002.

F. Berthou, F. Ceppo, K. Dumas, F. Massa, B. Vergoni et al., The Tpl2 kinase regulates the COX-2/prostaglandin E2 axis in adipocytes in inflammatory conditions, Mol Endocrinol, vol.29, pp.1025-1036, 2015.

A. G. Eliopoulos, C. D. Dumitru, C. Wang, J. Cho, and P. N. Tsichlis, Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals, EMBO J, vol.21, pp.4831-4840, 2002.

M. Y. Donath, Targeting inflammation in the treatment of type 2 diabetes: time to start, Nat Rev Drug Discov, vol.13, pp.465-476, 2014.

Y. Hu, N. Green, L. K. Gavrin, K. Janz, K. N. Li et al., Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis, Bioorg Medic Chem Lett, vol.16, pp.6067-6072, 2006.

M. Lawrenz, A. Visekruna, A. Kühl, N. Schmidt, S. Kaufmann et al., Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?, Mucosal Immunol, vol.5, pp.129-139, 2012.

I. Soria-castro, A. Krzyzanowska, M. L. Pelaéz, J. Regadera, G. Ferrer et al., Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation, J Biol Chem, vol.285, pp.33805-33815, 2010.

C. Broca, J. Quoyer, S. Costes, N. Linck, A. Varrault et al., beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells, J Biol Chem, vol.284, pp.4332-4342, 2009.

P. Bucher, Z. Mathe, P. Morel, D. Bosco, A. Andres et al., Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation, Transplantation, vol.79, pp.91-97, 2005.

M. A. Ravier, M. Leduc, J. Richard, N. Linck, A. Varrault et al., ?-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice, Diabetologia, vol.57, pp.532-541, 2014.

, Cell Death and Disease is an open-access journal published by